This article provides an overview of the latest advancements in the treatment of type 1 diabetes, starting with traditional insulin therapy and moving towards innovative technologies like artificial pancreas systems. It discusses the evolution of insulin formulations, including rapid-acting and long-acting insulins, and how they have improved blood glucose management. The article also covers continuous glucose monitoring (CGM) devices and insulin pumps, which have become essential tools in diabetes care. Finally, it highlights the development of artificial pancreas systems that combine CGM and insulin delivery, offering a more automated and precise approach to glucose control.
